More effective and safe autophagy inhibitors should be developed in the future, thus offering a promising therapeutic strategy to overcome resistance to EGFR inhibitors and to improve the anti-cancer effects of these agents for patients with advanced stage bladder cancer. This evidence concerns the gene EGFR and cancer.